Episurf announces outcome of directed share issue
NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA, SOUTH AFRICA, JAPAN, HONG KONG SWITZERLAND, SINGAPORE OR NEW ZEALAND OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL Subscription in the directed issue of no more than 3,713,814 shares of series B (the “Share Issue") and the directed issue of 2,252,210 warrants (the "Warrant Issue") that the board of Episurf Medical AB (publ) resolved upon in accordance with press release on 12 November 2018, and which were approved by the